Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Under the partnership to develop NFL-101, the company’s drug candidate Tobacco leaf protein for smoking cessation, for the Indian market with Themis Medicare Ltd., will purchase Active Pharmaceutical Ingredient (API) from NFL Biosciences.
Lead Product(s): Tobacco Leaf Protein
Therapeutic Area: Psychiatry/Psychology Product Name: NFL-101
Highest Development Status: Phase II/ Phase IIIProduct Type: Small molecule
Recipient: NFL Biosciences
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership October 05, 2022